Suppr超能文献

面部坏死性筋膜炎:病因、诊断和治疗的最新概念。

Necrotizing fasciitis of the face: current concepts in cause, diagnosis and management.

机构信息

University of Sydney, Sydney.

Department of Otolaryngology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.

出版信息

Curr Opin Otolaryngol Head Neck Surg. 2022 Aug 1;30(4):270-275. doi: 10.1097/MOO.0000000000000820.

Abstract

PURPOSE OF REVIEW

Necrotizing fasciitis of the face is uncommon but potentially life threatening. With adequate multidisciplinary treatment, mortality and has significantly improved. This article highlights current concepts and supporting literature in the management of facial necrotizing fasciitis.

RECENT FINDINGS

Management of necrotizing fasciitis involving the face requires a multisciplinary team approach, including early medical and surgical intervention. With early haemodynamic support, broad spectrum antibiotics and aggressive surgical debridement, mortality has reduced significantly. Soft-tissue reconstruction can be effectively utilized once the infection has been adequately treated. Although some adjunctive treatment such as vacuum assisted closure dressing has shown to be of benefit, other treatments such as hyperbaric oxygen remains controversial.

SUMMARY

Necrotizing fasciitis is an aggressive soft tissue involving that rapidly spreads along fascial planes. Necrotizing fasciitis involving the face is rare owing to its rich blood supply but is also difficult to manage due to the complex regional anatomy. Common sources are odontogenic, sinugenic, peritonsillar or salivary gland infections and often polymicrobial. The principles of treatment include early and aggressive haemodynamic support, broad spectrum antibiotics and aggressive surgical debridement. Often times repeat debridements following close monitoring is required. Reconstructive options are viable only after the infection has been adequately treated. Although mortality has significantly improved, mediastinal involvement, multiple comorbidities and delayed treatment confers a worse prognosis.

摘要

目的综述

面部坏死性筋膜炎并不常见,但可能危及生命。通过充分的多学科治疗,死亡率显著降低。本文重点介绍了面部坏死性筋膜炎的管理的最新概念和相关文献。

最新发现

涉及面部的坏死性筋膜炎的管理需要多学科团队的方法,包括早期的医疗和手术干预。通过早期的血流动力学支持、广谱抗生素和积极的手术清创,死亡率显著降低。一旦感染得到充分治疗,就可以有效地进行软组织重建。虽然一些辅助治疗,如真空辅助闭合敷料已被证明是有益的,但其他治疗,如高压氧仍然存在争议。

总结

坏死性筋膜炎是一种具有侵袭性的软组织感染,可沿筋膜平面迅速扩散。由于面部丰富的血液供应,坏死性筋膜炎很少见,但由于其复杂的区域解剖结构,也很难治疗。常见的病因包括牙源性、鼻窦源性、扁桃体周围或唾液腺感染,通常为多种微生物感染。治疗原则包括早期和积极的血流动力学支持、广谱抗生素和积极的手术清创。通常需要密切监测后进行多次清创。只有在感染得到充分治疗后,才能选择重建方案。尽管死亡率显著降低,但纵隔受累、多种合并症和延迟治疗会导致预后更差。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验